Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling

Stem Cell Rev Rep. 2024 Jul;20(5):1151-1161. doi: 10.1007/s12015-024-10713-7. Epub 2024 Apr 2.

Abstract

The CRISPR system, as an effective genome editing technology, has been extensively utilized for the construction of disease models in human pluripotent stem cells. Establishment of a gene mutant or knockout stem cell line typically relies on Cas nuclease-generated double-stranded DNA breaks and exogenous templates, which can produce uncontrollable editing byproducts and toxicity. The recently developed adenine base editors (ABE) have greatly facilitated related research by introducing A/T > G/C mutations in the coding regions or splitting sites (AG-GT) of genes, enabling mutant gene knock-in or knock-out without introducing DNA breaks. In this study, we edit the AG bases in exons anterior to achieve gene knockout via the ABE8e-SpRY, which recognizes most expanded protospacer adjacent motif to target the genome. Except for gene-knockout, ABE8e-SpRY can also efficiently establish disease-related A/T-to-G/C variation cell lines by targeting coding sequences. The method we generated is simple and time-saving, and it only takes two weeks to obtain the desired cell line. This protocol provides operating instructions step-by-step for constructing knockout and point mutation cell lines.

Keywords: Base editing; Disease model; Gene knockout; Human pluripotent stem cells; Point mutation.

MeSH terms

  • CRISPR-Cas Systems* / genetics
  • Cell Line
  • Gene Editing* / methods
  • Gene Knockout Techniques
  • Humans
  • Pluripotent Stem Cells* / cytology
  • Pluripotent Stem Cells* / metabolism